Big Pharma Split Corp Class A Strategic Asset Allocation Index
Big Pharma Split Corp Class A strategic asset allocation index. Big Pharma Split Corp Class A (PRM) has a Strategic Asset Allocation Index of 166.3% as of December 2025. Strategic assets (PP&E of CA$- plus long-term investments of CA$30.38 Million) total CA$30.38 Million, measured against net assets of CA$18.27 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PRM net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Big Pharma Split Corp Class A (2017–2025)
Strategic asset allocation index of Big Pharma Split Corp Class A from 2017 to 2025. This chart shows how Big Pharma Split Corp Class A's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2025. As of December 2025, the index stands at 166.3%, representing strategic assets of CA$30.38 Million against net assets of CA$18.27 Million CAD. Check Big Pharma Split Corp Class A tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Big Pharma Split Corp Class A Strategic Asset Allocation Index by Year (2017–2025)
Big Pharma Split Corp Class A strategic asset allocation index by year from 2017 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Big Pharma Split Corp Class A from 2017 to 2025, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PRM market cap.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 166.3% | CA$30.38 Million | CA$- | CA$30.38 Million | CA$18.27 Million | ▼ -17.7 pp |
| 2024 | 184.0% | CA$25.17 Million | CA$- | CA$25.17 Million | CA$13.68 Million | ▲ +18.4 pp |
| 2023 | 165.6% | CA$26.25 Million | CA$- | CA$26.25 Million | CA$15.85 Million | ▲ +42.6 pp |
| 2022 | 123.0% | CA$24.27 Million | CA$- | CA$24.27 Million | CA$19.73 Million | ▼ -38.2 pp |
| 2021 | 161.3% | CA$36.13 Million | CA$- | CA$36.13 Million | CA$22.40 Million | ▼ -9.0 pp |
| 2020 | 170.2% | CA$22.45 Million | CA$- | CA$22.45 Million | CA$13.19 Million | ▼ -5.7 pp |
| 2018 | 175.9% | CA$33.14 Million | CA$- | CA$33.14 Million | CA$18.84 Million | ▲ +11.9 pp |
| 2017 | 164.0% | CA$30.63 Million | CA$- | CA$30.63 Million | CA$18.68 Million | — |